Skip to main content
SpringerLink
Log in

Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy

  • Practice Point
  • Published:

From Nature Clinical Practice Endocrinology & Metabolism

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Vance ML et al. (1984) Drugs five years later. Bromocriptine. Ann Intern Med 100: 78–91

    Article  CAS  Google Scholar 

  2. Verhelst J et al. (1999) Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab 84: 2518–2522

    Article  CAS  Google Scholar 

  3. Zarate A et al. (1983) Follow-up of patients with prolactinomas after discontinuation of long-term therapy with bromocriptine. Acta Endocrinol (Copenh) 104: 139–142

    Article  CAS  Google Scholar 

  4. Passos VQ et al. (2002) Long-term follow-up of prolactinomas: normoprolactinemia after bromocriptine withdrawal. J Clin Endocrinol Metab 87: 3578–3582

    Article  CAS  Google Scholar 

  5. Colao A et al. (2003) Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N Engl J Med 349: 2023–2033

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Ian Newman, Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Endocrinology and Chief of the Division of Endocrinology and Metabolism, Neuroendocrine Unit, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil

    Marcello D Bronstein

Authors
  1. Marcello D Bronstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcello D Bronstein.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bronstein, M. Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy. Nat Rev Endocrinol 2, 130–131 (2006). https://doi.org/10.1038/ncpendmet0135

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0135

  • Springer Nature Limited

This article is cited by

Search

Navigation